4//SEC Filing
RYLL DENNIS L 4
Accession 0001181431-06-038226
CIK 0001310094other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 2:37 PM ET
Size
6.8 KB
Accession
0001181431-06-038226
Insider Transaction Report
Form 4
RYLL DENNIS L
Director
Transactions
- Other
Common Stock
2006-04-03$8.00/sh+5,339$42,712→ 3,634,160 total(indirect: By MOAB Investment, LP.) - Other
Common Stock
2006-04-03$8.00/sh+252$2,016→ 34,414 total
Footnotes (2)
- [F1]Represents the receipt of shares of common stock in lieu of accrued but unpaid dividends on the Company's former Series E Convertible Preferred Stock at a price of $8.00 a share.
- [F2]Mr. Ryll is a limited partner in the MOAB Investment LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeother
Related Parties
1- filerCIK 0001320102
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 2:37 PM ET
- Size
- 6.8 KB